发明名称 PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIES
摘要 The present invention mainly aims to provide a drug for the prophylaxis or treatment of androgen-independent prostate cancer, which is highly useful as a pharmaceutical agent. The present invention provides a drug for the prophylaxis or treatment of androgen-independent prostate cancer, containing a steroid C17,20 lyase inhibitor, particularly, a compound represented by the formula (I):;;wherein n is an integer of 1 to 3, and Ar is an aromatic ring optionally having substituent(s), or a salt thereof or a prodrug thereof.
申请公布号 US2014256693(A1) 申请公布日期 2014.09.11
申请号 US201414173388 申请日期 2014.02.05
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 Yamaoka Masuo;Hara Takahito
分类号 C07D487/04;A61K45/06;A61K31/4188 主分类号 C07D487/04
代理机构 代理人
主权项 1. A method for preventing or treating androgen-independent prostate cancer in a mammal, which comprises administering an effective amount of a steroid C17,20 lyase inhibitor to said mammal.
地址 Osaka-Shi JP